Zeleris 400 mg Solution is a Health Canada–registered veterinary drug (DIN 02501015) held by Ceva Animal Health Inc, containing Florfenicol. Health Canada lists its status as Marketed (status date 19 Oct 2020). Nexara Health has matched 86 registrations of Florfenicol across 5 other regulated markets.
Health Canada registration
| DIN | 02501015 |
|---|---|
| Brand name | Zeleris |
| Active ingredient | Florfenicol |
| Strength | 400 mg |
| Dosage form | Solution |
| Route | Subcutaneous |
| Company | Ceva Animal Health Inc |
| Status | Marketed — 19 Oct 2020 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Florfenicol registered in other markets
86 registrations of the same molecule in 5 national registries outside Canada (first 29 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Amphen | Huvepharma NV | 200 mg/ml | suspension til anvendelse i drikkevand | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Amphen | Huvepharma NV | 200 mg/g | granulat til anvendelse i drikkevand | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Cadorex Vet. | Livisto Int´l S.L. | 300 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Fenflor | KRKA d.d. Novo mesto | 300 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Flordofen | Dopharma Research B.V. | 300 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Florfenis | Laboratorios Syva S.A. | 300 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Florgane | Emdoka | 300 mg/ml | injektionsvæske, suspension | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Florkem | Ceva Sante Animale | 300 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Iceland | Aquaflor vet | Vistor - óskráð | duft | 0 | Lyfjastofnun lyfjaverdskra | |
| Iceland | Florocol Vet | Distica - óskráð lyf | 500 mg | kyrni | 0 | Lyfjastofnun lyfjaverdskra |
| Malaysia | Chemflor-100 Oral Solution 100 mg/mL | Genpharma Sdn. Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Em-Taikomix 10% Granules | Range Pharma Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | FENIFLOR 100mg/ml ORAL SOLUTION | F.e. Venture Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Flor Excel 250mg/ml Oral Solution | F.e. Venture Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Flor-Ld 100mg/mL Oral Solution | Kty Chemicals Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Flor-Ld 200mg/mL Oral Solution | Kty Chemicals Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Florcol Oral Solution 100mg/ml | Y.s.p. Industries (M) Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | FLORCOSOL 10% Oral Solution | Lim Seng Pharmachem Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Alphaflorosol | ALPHAVET Zrt. | 100 mg/ml | Roztwór do podania w wodzie do picia | Bezterminowe | URPL RPL |
| Poland | Alphaflorovet | Alphavet Zrt. | 20 mg/g | Premiks do sporządzania paszy leczniczej | Bezterminowe | URPL RPL |
| Poland | Amphen | Huvepharma NV | 200 mg/ml | Zawiesina do podania w wodzie do picia | Bezterminowe | URPL RPL |
| Poland | Amphen | Huvepharma NV | 200 mg/g | Granulat do podania w wodzie do picia | Bezterminowe | URPL RPL |
| Poland | Belaflor | Bela-Pharm GmbH & Co. KG | 200 mg/ml | Roztwór do podania w wodzie do picia | Bezterminowe | URPL RPL |
| Poland | Cadorex | Industrial Veterinaria, S.A. | 100 mg/ml | Roztwór do podania w wodzie do picia | Bezterminowe | URPL RPL |
| Poland | Cadorex | Industrial Veterinaria, S.A. | 300 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Flordofen | Dopharma Research B.V. | 100 mg/1 ml | Roztwór do podania w wodzie do picia | Bezterminowe | URPL RPL |
| United States | Florfenicol | Minsheng Group Shaoxing Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Florfenicol | Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Florfenicol | Shandong Guobang Pharmaceutical Co., Ltd. | Powder | FDA NDC |
See every manufacturer of Florfenicol worldwide →
Regulator price references for Florfenicol
Published list or reimbursement prices for Florfenicol presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Aquaflor vet | poki | 222,412.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | Florocol Vet | 500mg | pakkar | 255,488.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Zeleris (DIN 02501015) marketed in Canada?
Yes. Health Canada lists DIN 02501015 as Marketed as of 19 Oct 2020.
Who holds the Canadian licence for this product?
Ceva Animal Health Inc is the company of record in the Health Canada Drug Product Database.
Is Florfenicol registered outside Canada?
Yes — Nexara Health has matched 86 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02501015, status date 2020-10-19; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02501015, status date 2020-10-19; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02501015, status date 2020-10-19; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.